GLP-1 medicines before anesthesia: what your care team needs to know

Why a weight-management medicine matters to anesthesia

The relevant effect is delayed gastric emptying: food can remain in the stomach longer. During general anesthesia or deep sedation, stomach contents can come back up and enter the airway or lungs. This is called aspiration, and it can be serious. The American Society of Anesthesiologists’ patient explanation describes why knowing about GLP-1 use helps the anesthesia team plan.

The issue can arise during a procedure involving deep sedation, as well as an operation. The UK medicines regulator’s safety notice addresses both GLP-1 and dual GIP/GLP-1 medicines. Tell the team the actual drug name rather than assuming that “weight-loss treatment” gives them enough information.

The Zepbound prescribing information, for example, reports rare aspiration events in patients using GLP-1 medicines despite reported adherence to fasting instructions. It also says data are insufficient to establish whether temporarily stopping Zepbound or changing fasting instructions reduces retained stomach contents. That is a reason for individual assessment, not for inventing a longer fast yourself.

Why you may have seen different instructions online

The 2024 US multisociety guidance describes a shared decision involving the procedural, anesthesia and prescribing teams. It allows continuation for people without elevated risk and weighs any decision to withhold treatment against medical consequences, such as worsening blood sugar control. The authors explicitly acknowledge limited evidence.

The ASA summary says most patients can continue before elective surgery. That statement is not a personal clearance to follow your usual routine. Recent dose increases, gastrointestinal symptoms and other causes of slow stomach emptying can change the assessment. A team may choose dietary preparation, a different anesthesia approach, a stomach ultrasound or a delay in the procedure.

An old social-media instruction, another patient’s preparation sheet and your own procedure plan can describe different circumstances. If instructions conflict, contact the procedure team and prescriber to reconcile them. Ask for one current written plan covering medication and food or drink, rather than trying to combine incompatible directions.

Send a medication record before the pre-procedure call

A useful record is specific enough that the teams can identify what you take and what has changed. Copy the prescription or pharmacy label accurately; do not convert between milligrams and syringe units from memory. Include the reason for treatment, such as diabetes or weight management.

Use this as a preparation list for a conversation, not as a rule for deciding whether a procedure can proceed:

• Medicine name, formulation, prescribed dose and dosing schedule; include whether the preparation is compounded.
• Date and time of the most recent dose, and any recent start, restart or dose change.
• Current nausea, vomiting, abdominal discomfort, constipation or other symptoms the team should assess.
• Other medicines and supplements, relevant health conditions, and the prescriber’s contact details.
• Procedure date, facility and contact person, plus any preparation instructions already received.

Add a second handoff when the procedure is away from home

If you are travelling for a procedure, the clinician who knows your weight-management history may be in a different service from the team performing it. Ask how the relevant medication record and clinical instructions will reach both teams. Confirm who handles questions before departure and after discharge.

Our travel follow-up guide separates the itinerary, delivery and clinical contact questions. A confirmed hotel booking or delivery address does not establish access to prescribing or follow-up at that destination. This article does not provide destination-specific licensing or import advice.

The UK regulator’s notice and US guidance both make disclosure of GLP-1 treatment relevant to procedure planning. The team responsible for your care must apply the appropriate local arrangements and assess your situation. Neither a review website nor a routine order confirmation can make that decision.

Use CoreAge Rx clinical messaging for the prescriber’s part

CoreAge Rx says communication with its prescribing physician takes place through member-portal messages, generally with a response in one to three business days. If you use the service, raise an upcoming procedure early enough for that asynchronous discussion and give the prescriber the procedure team’s instructions.

You might ask: “My procedure team has requested a GLP-1 medication plan. What information should I send them, and who will confirm any interruption and restart instructions?” This is a suggested question, not an instruction to interrupt treatment. Send the answer to the procedure team through its approved process and resolve any remaining disagreement.

CoreAge Rx lists compounded semaglutide and tirzepatide. These are not FDA-approved, and the FDA’s compounded GLP-1 guidance remains relevant when evaluating the proposed product. The Zepbound label cited above is an example from an approved medicine; it does not establish approval or clinical outcomes for a CoreAge Rx preparation. Our CoreAge Rx review provides the service context.

Keep the team informed if the situation changes

Tell the facility if symptoms develop, the procedure date changes, or you have already taken a dose that differs from the agreed plan. Report what happened accurately. The clinical team can decide what assessment or change is needed; hiding a detail to avoid a postponement removes information they need.

For an emergency, seek local emergency care and tell the treating team what you take and when you last took it. Do not wait for a portal reply. The ASA patient guidance addresses emergency surgery separately because it cannot rely on the same advance preparation as an elective procedure.

Common questions

Keep researching

• Plan weight-management follow-up while travelling
• Research the CoreAge Rx service
• More health articles